Three-phase course of central diabetes insipidus in a child after removal of craniopharyngioma: a clinical case


DOI: https://dx.doi.org/10.18565/pharmateca.2022.11-12.96-98

N.A. Strebkova, A.L. Kalinin

National Medical Research Center for Endocrinology, Moscow, Russia
Background. Central diabetes insipidus (CDI) is a fairly common complication of neurosurgical removal of the chiasmal-sellar region (CSR) tumors. In some cases, postoperative CDI has a three-phase course. At the same time, each of the stages of the condition requires a differentiated approach based on the obtained clinical and laboratory data.
Description of the clinical case. A description of the three-phase course of CDI that developed in a child after neurosurgical removal of a giant endosuprasellar craniopharyngioma is presented. Determining the phase of the process was based on indicators of water bal- ance, blood serum electrolytes and osmolality, urine osmolality. During the first and third phases, normo- and hypernatremia (140–153 mmol/l) with simultaneous polyuria and polydipsia was noted; the second phase was characterized by hyponatremia (132–134 mmol/l), high-normal urine osmolality (790–1190 mOsm/kg), oliguria and lack of thirst. During the first and third phases, substitution therapy with desmopressin preparations was carried out with a free drinking regimen. During the second phase, fluid intake was sharply limited in combination with dietary salt supplementation (3–5 g/day) and desmopressin withdrawal.
Conclusion. The course of diabetes insipidus after neurosurgical removal of the CSR tumor requires careful monitoring in the postop- erative period. Timely detection of the three-phase course of CND and a differentiated approach to the tactics of managing a child in each of the phases make it possible to avoid significant excursion in the blood electrolyte levels up to the development of life-threatening conditions.

About the Autors


Corresponding author: Natalya A. Strebkova, Cand. Sci. (Med.). Leading Researcher at the Department of Tumors of the Endocrine System in Children, Institute of Pediatric Endocrinology, Scientific Medical Research Center of Endocrinology, Moscow, Russia; strebcovanata@gmail.com


Similar Articles


Бионика Медиа